Abstract
OBJECTIVE: To identify the relationship between anxiety and depression with the severity of fibromyalgia and quality of life in patients aged 18 to 65 years, clinic of rheumatology of Barranquilla. 
 
 METHODS: Observational, descriptive, comparative cross-sectional study. Patients with fibromyalgia who attend the external consultation of rheumatology will be surveyed. The questionnaires to be applied are the Fibromyalgia Impact Questionnaire Revised (Spanish version), Health Questionnaire SF-36, Patient Health Questionnaire and a Scale of 7 questions for generalized anxiety disorder. The data collected in this descriptive study will be analyzed by means of frequency and association measures. The analysis of association between sociodemographic factors and clinical characteristics will be carried out with bivariate analysis and the comparison of qualitative or categorical variables will be done through the analysis of variance, to compare variables of ordinal type and variables of type ratio. 
 
 RESULTS: 34.2% of the patients did not present anxiety whereas 83.6% of the patients had some degree of depression. 50% of the patients had moderate, severe and extreme degrees of depression. An association was found between severity of fibromyalgia with anxiety, depression and quality of life (p <0.05). 
 
 CONCLUSION: A directly proportional relationship was found between the severity of depression and anxiety and the severity of FM. An elevated score in the FIQR, lower weighted scores for quality of life in the participants, in addition to greater severity in the scales GAD - 7 and PHQ - 9, all score to lower quality of life.
Highlights
Fibromyalgia is a medical condition, neither progressive nor degenerative, whose prevalence varies from 2% to 4% in the general population
34.2% of the patients did not present anxiety whereas 83.6% of the patients had some degree of depression. 50% of the patients had moderate, severe and extreme degrees of depression
An association was found between severity of fibromyalgia with anxiety, depression and quality of life (p
Summary
Fibromyalgia is a medical condition, neither progressive nor degenerative, whose prevalence varies from 2% to 4% in the general population. Within the symptomatic spectrum of this entity are widespread chronic pain, fatigue, mood disorders, sleep disturbances and deterioration of quality of life (Kaltsas & Tsiveriotis, 2013; Talotta et al, 2017). Pain is the predominant symptom, being accompanied more frequently by cognitive deterioration and sleep disorders. Alodinia and hyper- algesia can be found (Kaltsas & Tsiveriotis, 2013). Comorbidity with psychiatric disorders are frequent, with depression and anxiety being the most common. The frequency for depressive disorder ranges between 20% and 80%, while for anxiety disorder ranges from 13% to 63.8% (de Vida & Fibromialgia, 2010; Fietta & Manganelli, 2007)
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
